KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.

NK cells are promising cellular therapeutics against hematological and solid malignancies. Immunogenetic studies have identified that various activating killer cell Ig-like receptors (KIRs) are associated with cancer outcomes. Specifically, KIR2DS2 has been associated with reduced incidence of relapse following transplant in hematological malignancies and improved outcomes in solid tumors, but the mechanism remains obscure. Therefore, we investigated how KIR2DS2 expression impacts NK cell function. Using a novel flow cytometry panel, we show that human NK cells with high KIR2DS2 expression have enhanced spontaneous activation against malignant B cell lines, liver cancer cell lines, and primary chronic lymphocytic leukemia cells. Surface expression of CD16 was increased on KIR2DS2high NK cells, and, accordingly, KIR2DS2high NK cells had increased activation against lymphoma cells coated with the clinically relevant anti-CD20 Abs rituximab and obinutuzumab. Bulk RNA sequencing revealed that KIR2DS2high NK cells have upregulation of NK-mediated cytotoxicity, translation, and FCGR gene pathways. We developed a novel single-cell RNA-sequencing technique to identify KIR2DS2+ NK cells, and this confirmed that KIR2DS2 is associated with enhanced NK cell-mediated cytotoxicity. This study provides evidence that KIR2DS2 marks a population of NK cells primed for anticancer activity and indicates that KIR2DS2 is an attractive target for NK-based therapeutic strategies.

Igf-ii y la gonddotropina coriónica regulan la roliferación, migración e invassión de células de trofoblasto humano / IGF-II and Chorionic Gonadotropin Regulate Proliferation, Migration and Invasion of Human Trophoblast Cells

Son conocidas las propiedades del factor de crecimiento similar a la insulina tipo II (IGF-II) y de la hormona gonadotropina coriónica (hCG) en implantación y migración trofoblástica; sin embargo, los mecanismos moleculares a través de los cuales ejercen sus efectos no están completamente caracterizados. El objetivo de este estudio fue establecer la interacción potencial entre los efectos funcionales de hCG e IGF-II en la regulación de la proliferación, migración e invasión trofoblástica. Utilizando la línea celular HTR-8/SVneo de trofoblasto extravelloso se estableció que IGF-II promueve la proliferación celular y de manera novedosa se demostró que hCG, a concentraciones elevadas, es capaz de estimular la proliferación trofoblástica, a través de un mecanismo independiente al empleado por IGF-II. En contraste, la capacidad invasiva del trofoblasto fue regulada por IGF-II y hCG, planteando la existencia de un efecto aditivo en sus acciones. En conclusión, nuestros resultados demuestran el papel de hCG e IGF-II en la regulación de la proliferación e invasión del trofoblasto y plantean la existencia de interacciones a nivel de sus acciones biológicas, contribuyendo a un mejor entendimiento de la biología del trofoblasto y sus patologías.

Both IGF-II and chorionic gonadotropin (hCG) are important regulators of human trophoblast migration and implantation; however the molecular mechanisms are not fully understood. The purpose of this study was to determine the potential cross-talk between functional effects of hCG and IGF-II in the regulation of trophoblast proliferation, migration and invasion. Using the HTR-8/SVneo trophobast cell line we found that IGF-II stimulates cell proliferation and, for the first time we demonstrate that hCG at high doses is able to promote trophoblast proliferation through a mechanism independent of IGF-II. In contrast, trophoblast invasiveness was regulated by both IGF-II and hCG and an additive effect between the two hormones was observed. In conclusion, our results demonstrate cross-talk between the biological activities of IGF-II and hCG in the regulation of trophoblast invasiveness and contribute to a better understanding of the trophoblast biology and pathology.

La proteomica n la era postgenómica / The Proteomics In The Postgenomic Era

El principal desafío de la biología moderna es entender la expresión, función y regulación del conjunto completo de proteínas codificadas por un organismo, lo cual describe el objetivo del nuevo campo de la proteómica. Las proteínas son las efectoras del trabajo celular, por ello el estudio de sus perfiles globales de expresión y de sus cambios bajo determinadas condiciones fisiológicas o patológicas, permite entender la red compleja de interacciones en que se basa el funcionamiento de una célula. La electroforesis en dos dimensiones (2D-PAGE) es la técnica central de la proteómica. En la actualidad no existe otro método con la capacidad para resolver simultáneamente miles de proteínas en un solo procedimiento y para detectar modificaciones post y co-traduccionales imposibles de predecir a partir de la secuencia genómica. Sus aplicaciones incluyen el análisis de proteomas, señalización, detección de marcadores de enfermedades y cáncer.

The main challenge of modern biology is to understand the expression, function and regulation of the whole set of proteins codified by an organism, which is the objective of the new field of proteomics. Proteins are the effectors of cellular work and the knowledge of their global expression profiles and changes under physiological and pathological conditions can help us to understand the complex network of interactions involved in cellular function. Two-dimensional electrophoresis (2-DE) is the central technology in proteomics. At present no other technique has the throughput and high resolution of 2-DE for the separation of thousands of proteins in one procedure and for the analysis of post-and co-translation modifications, not predictable from the genome sequence. The scope of applications extends from proteome analysis, to cell signaling, disease markers and cancer.